Posterior limb of the internal capsule predicts poor quality of life in patients with Parkinson’s disease: connectometry approach

  • Farzaneh Ghazi Sherbaf
  • Mahtab Mojtahed Zadeh
  • Maryam Haghshomar
  • Mohammad Hadi Aarabi
Original Article


Psychiatric symptoms and motor impairment are major contributions to the poor quality of life in patients with Parkinson's disease (PD). Here, we applied a novel diffusion-weighted imaging approach, diffusion MRI connectometry, to investigate the correlation of quality of life, evaluated by Parkinson's Disease Questionnaire (PDQ39) with the white matter structural connectivity in 27 non-demented PD patients (disease duration of 5.3 ± 2.9 years, H and Y stage = 1.5 ± 0.6, UPDRS-III = 13.7 ± 6.5, indicating unilateral and mild motor involvement). The connectometry analysis demonstrated bilateral posterior limbs of the internal capsule (PLIC) with increased connectivity related to the higher quality of life (FDR = 0.027) in a multiple regression model. The present study suggests for the first time a neural basis of the quality of life in PD in the light of major determinants of poor quality of life in these patients: anxiety, depression, apathy and motor impairment. Results in our sample of non-demented PD patients with relatively mild motor impairment and no apparent sign of depression/anxiety also identify a unique and inexplicable association of the PLIC to the quality of life in PD patients.


Quality of life Parkinson’s disease Diffusion MRI Connectometry 



This dataset was supported by the Belgian National Fund for Scientific Research, the University of Liège, the Queen Elisabeth Medical Foundation, the Léon Fredericq Foundation, the Belgian Inter-University Attraction Program, the Walloon Excellence in Life Sciences and Biotechnology program, and the Marie Curie Initial Training Network in Neurophysics (PITN-GA-2009-238593).

Author contributions

FGS and MHA contributed to the conception and design of the study; MHA, FGS, MMZ and MH contributed to data collection and analysis. FGS and MHA contributed to writing the manuscript.

Compliance with ethical standards

Ethics approval and consent to participate

All procedures performed here including human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Availability of data and material

Data used in this study is accessible via:

Conflict of interests

The authors declare that they have no competing interests.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Opara JA et al (2012) Quality of life in Parkinson’s disease. J Med Life 5(4):375–381PubMedPubMedCentralGoogle Scholar
  2. 2.
    Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8(5):464–474CrossRefPubMedGoogle Scholar
  3. 3.
    Santos-Garcia D, de la Fuente-Fernandez R (2013) Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson’s disease. J Neurol Sci 332(1–2):136–140CrossRefPubMedGoogle Scholar
  4. 4.
    Scalzo P et al (2009) Depressive symptoms and perception of quality of life in Parkinson’s disease. Arq Neuropsiquiatr 67(2A):203–208CrossRefPubMedGoogle Scholar
  5. 5.
    Martinez-Martin P (2011) The importance of non-motor disturbances to quality of life in Parkinson’s disease. J Neurol Sci 310(1):12–16CrossRefPubMedGoogle Scholar
  6. 6.
    Montel S, Bonnet A-M, Bungener C (2009) Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson’s disease. J Geriatr Psychiatry Neurol 22(2):95–102CrossRefPubMedGoogle Scholar
  7. 7.
    Elbers RG et al (2014) Impact of fatigue on health-related quality of life in patients with Parkinson’s disease: a prospective study. Clin Rehabil 28(3):300–311CrossRefPubMedGoogle Scholar
  8. 8.
    Menza MA, Robertson-Hoffman DE, Bonapace AS (1993) Parkinson’s disease and anxiety: comorbidity with depression. Biol Psychiatry 34(7):465–470CrossRefPubMedGoogle Scholar
  9. 9.
    Jellinger KA (2014) The pathomechanisms underlying Parkinson’s disease. Expert Rev Neurother 14(2):199–215CrossRefPubMedGoogle Scholar
  10. 10.
    Hall JM et al (2016) Diffusion alterations associated with Parkinson’s disease symptomatology: a review of the literature. Parkinsonism Relat Disord 33:12–26CrossRefPubMedGoogle Scholar
  11. 11.
    Ziegler E et al (2014) Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson’s disease. Neuroimage 99:498–508CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Hobson DE et al (2002) Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 287(4):455–463CrossRefPubMedGoogle Scholar
  13. 13.
    Peto V et al (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4(3):241–248CrossRefPubMedGoogle Scholar
  14. 14.
    Yeh F-C, Tseng W-YI (2011) NTU-90: a high angular resolution brain atlas constructed by q-space diffeomorphic reconstruction. Neuroimage 58(1):91–99CrossRefPubMedGoogle Scholar
  15. 15.
    Yeh FC, Badre D, Verstynen T (2016) Connectometry: a statistical approach harnessing the analytical potential of the local connectome. Neuroimage 125:162–171CrossRefPubMedGoogle Scholar
  16. 16.
    Yeh FC et al (2013) Deterministic diffusion fiber tracking improved by quantitative anisotropy. PLoS One 8(11):e80713CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMedGoogle Scholar
  18. 18.
    Kim YH et al (2008) Corticospinal tract location in internal capsule of human brain: diffusion tensor tractography and functional MRI study. NeuroReport 19(8):817–820CrossRefPubMedGoogle Scholar
  19. 19.
    Castrioto A et al (2016) Emotional manifestations of PD: neurobiological basis. Mov Disord 31(8):1103–1113CrossRefPubMedGoogle Scholar
  20. 20.
    Postuma RB, Berg D (2016) Advances in markers of prodromal Parkinson disease. Nature Reviews Neurology 12(11):622–634CrossRefPubMedGoogle Scholar
  21. 21.
    Jones JD et al (2015) Anxiety and depression are better correlates of Parkinson’s disease quality of life than apathy. J Neuropsychiatry Clin Neurosci 27(3):213–218CrossRefPubMedGoogle Scholar
  22. 22.
    Liao M et al (2014) White matter abnormalities in adolescents with generalized anxiety disorder: a diffusion tensor imaging study. BMC Psychiatry 14:41CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Kim MK et al (2017) White matter correlates of anxiety sensitivity in panic disorder. J Affect Disord 207:148–156CrossRefPubMedGoogle Scholar
  24. 24.
    Tinaz S, Courtney MG, Stern CE (2011) Focal cortical and subcortical atrophy in early Parkinson’s disease. Mov Disord 26(3):436–441CrossRefPubMedGoogle Scholar
  25. 25.
    Haber S (2016) Perspective on basal ganglia connections as described by Nauta and Mehler in 1966: where we were and how this paper effected where we are now. Brain Res 1645:4–7CrossRefPubMedGoogle Scholar
  26. 26.
    Barone P et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649CrossRefPubMedGoogle Scholar
  27. 27.
    van Almenkerk S et al (2015) Apathy among institutionalized stroke patients: prevalence and clinical correlates. Am J Geriatr Psychiatry 23(2):180–188CrossRefPubMedGoogle Scholar
  28. 28.
    Dujardin K et al (2009) Apathy may herald cognitive decline and dementia in Parkinson’s disease. Mov Disord 24(16):2391–2397CrossRefPubMedGoogle Scholar
  29. 29.
    Zheng Z et al (2014) DTI correlates of distinct cognitive impairments in Parkinson’s disease. Hum Brain Mapp 35(4):1325–1333CrossRefPubMedGoogle Scholar
  30. 30.
    Seminowicz DA et al (2004) Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 22(1):409–418CrossRefPubMedGoogle Scholar
  31. 31.
    Xiao J et al (2015) Altered white matter integrity in individuals with cognitive vulnerability to depression: a tract-based spatial statistics study. Sci Rep 5:9738CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Sacchet MD et al (2014) Structural abnormality of the corticospinal tract in major depressive disorder. Biol Mood Anxiety Disord 4:8–8CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Schrag A, Jahanshahi M, Quinn NP (2001) What contributes to depression in Parkinson’s disease? Psychol Med 31(1):65–73CrossRefPubMedGoogle Scholar
  34. 34.
    Schnitzler A et al (1997) Involvement of primary motor cortex in motor imagery: a neuromagnetic study. Neuroimage 6(3):201–208CrossRefPubMedGoogle Scholar
  35. 35.
    Iseki K et al (2015) Freezing of gait and white matter changes: a tract-based spatial statistics study. J Clin Mov Disord 2:1CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Wang M et al (2016) Alterations of functional and structural connectivity of freezing of gait in Parkinson’s disease. J Neurol 263(8):1583–1592CrossRefPubMedGoogle Scholar
  37. 37.
    Yeh F-C et al (2016) Quantifying differences and similarities in whole-brain white matter architecture using local connectome fingerprints. PLoS Comput Biol 12(11):e1005203CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Belgian Neurological Society 2018

Authors and Affiliations

  1. 1.Faculty of MedicineTehran University of Medical SciencesTehranIran
  2. 2.Department of RadiologyTehran University of Medical SciencesTehranIran

Personalised recommendations